CASIA OpenIR  > 中国科学院分子影像重点实验室
Development and validation of a radiomics-based method for macrovascular invasion prediction in hepatocellular carcinoma with prognostic implication
Wei Jingwei1,2,3; Fu Sirui4; Zhang Shuaitong1,2,3; Zhang Jie5; Gu Dongsheng1,2,3; Li Xiaoqun6; Chen Xudong7; He Xiaofeng8; Yan Jianfeng9; Lu Ligong4; Tian Jie1,2,3
2019-02
会议名称SPIE 国际光学工程学会年会
会议日期2019年2月20日
会议地点美国圣地亚哥
摘要

In hepatocellular carcinoma (HCC), more than one third of patients were accompanied by macrovascular invasion (MaVI) during diagnosis and treatment. HCCs with MaVI presented with aggressive tumor behavior and poor survival. Early identification of HCCs at high risk of MaVI would promote adequate preoperative treatment strategy making, so as to prolong the patient survival. Thus, we aimed to develop a computed tomography (CT)-based radiomics model to preoperatively predict MaVI status in HCC, meanwhile explore the prognostic prediction power of the radiomics model.

A cohort of 452 patients diagnosed with HCC was collected from 5 hospitals in China with complete CT images, clinical data, and follow-ups. 15 out of 708 radiomic features were selected for MaVI prediction using LASSO regression modeling. A radiomics signature was constructed by support vector machine based on the 15 selected features. To evaluate the prognostic power of the signature, Kaplan-Meier curves with log-rank test were plotted on MaVI occurrence time (MOT), progression free survival (PFS) and overall survival (OS).

The radiomics signature showed satisfactory performance on MaVI prediction with area under curves of 0.885 and 0.770 on the training and external validation cohorts, respectively. Patients could successfully be divided into high- and low-risk groups on MOT and PFS with p-value of 0.0017 and 0.0013, respectively. Regarding to OS, the Kaplan-Meier curve did not present with significant difference which may be caused by non-uniform following treatments after disease progression.

To conclude, the proposed radiomics model could facilitate MaVI prediction along with prognostic implication in HCC management.

关键词hepatocellular carcinoma macrovascular invasion prognosis computed tomography radiomics prediction
收录类别EI
七大方向——子方向分类医学影像处理与分析
文献类型会议论文
条目标识符http://ir.ia.ac.cn/handle/173211/23677
专题中国科学院分子影像重点实验室
通讯作者Lu Ligong; Tian Jie
作者单位1.Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China
2.Beijing Key Laboratory of Molecular Imaging, Beijing 100190, China
3.University of Chinese Academy of Sciences, Beijing 100049, China
4.Center of Intervention Radiology, Center of Precise Medicine, Zhuhai People’s Hospital, Zhuhai, China
5.Department of Radiology, Center of Precise Medicine, Zhuhai People’s Hospital Zhuhai, China
6.Department of Interventional Treatment, Zhongshan City People's Hospital, Zhongshan, China
7.Department of Radiology, Shenzhen People’s Hospital, Shenzhen, China
8.Interventional Diagnosis and Treatment Department, Nanfang Hospital, Southern Medical University, Guangzhou, China
9.Department of Radiology, Yangjiang People’s hospital, Yangjiang, China
第一作者单位中国科学院自动化研究所
通讯作者单位中国科学院自动化研究所
推荐引用方式
GB/T 7714
Wei Jingwei,Fu Sirui,Zhang Shuaitong,et al. Development and validation of a radiomics-based method for macrovascular invasion prediction in hepatocellular carcinoma with prognostic implication[C],2019.
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
EI-1_Wei_Article_1f3(303KB)会议论文 开放获取CC BY-NC-SA浏览 下载
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wei Jingwei]的文章
[Fu Sirui]的文章
[Zhang Shuaitong]的文章
百度学术
百度学术中相似的文章
[Wei Jingwei]的文章
[Fu Sirui]的文章
[Zhang Shuaitong]的文章
必应学术
必应学术中相似的文章
[Wei Jingwei]的文章
[Fu Sirui]的文章
[Zhang Shuaitong]的文章
相关权益政策
暂无数据
收藏/分享
文件名: EI-1_Wei_Article_1f36c6db-0242-4754-a1ba-2e7539b52dcc.pdf
格式: Adobe PDF
此文件暂不支持浏览
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。